Emergent BioSolutions (EBS) Misses Q1 EPS by 22c, Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
- Wall Street dips as higher yields, rising oil prices mark shaky start to SeptemberÂ
- Oil prices jump 4% as fresh US-Iran fighting stokes supply fears
- Two Saudi tankers struck in Strait of Hormuz Monday
- Fed’s Barr backs rate hike if inflation fails to cool, September odds hit 66%
- The Warsh pivot markets didn't expect
Emergent BioSolutions Reports First Quarter 2019 Financial Results
May 2, 2019 4:06 PM EDTReaffirms full year 2019 financial forecast and operational goalsProvides Q2 2019 revenue forecast of $200M-$220M
GAITHERSBURG, Md., May 02, 2019 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) reported financial results for the three months ended March 31, 2019.
FINANCIAL HIGHLIGHTS
(in... More